Mikael Hellstrom
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Contrast-enhanced CT-Nephrotoxic or not? A critical review of propensity-score-adjusted studies.
Journal: Journal of internal medicine
Published: April 19, 2026
A randomized controlled trial comparing non-selective versus selective TIRADS-based cytology in thyroid cancer diagnostics.
Journal: The British journal of surgery
Published: January 19, 2026
Computed tomography urography in macroscopic hematuria: a retrospective study with implications for standard care pathway.
Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: December 18, 2025
Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial.
Journal: Nature medicine
Published: July 24, 2025
Results after Four Years of Screening for Prostate Cancer with PSA and MRI.
Journal: The New England journal of medicine
Published: September 25, 2024
How a population-based cohort of men estimate lifetime risk of prostate cancer in a survey before entering a prostate cancer screening trial in Sweden?
Journal: BMJ open
Published: August 17, 2024
Effects of iodine contrast media on thyroid function - a prospective study.
Journal: European thyroid journal
Published: July 31, 2024
No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial.
Journal: European journal of endocrinology
Published: May 27, 2024
Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy.
Journal: European urology oncology
Published: August 21, 2023
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial.
Journal: European urology
Published: May 22, 2023
Last Updated: 09/26/2026